Search by Drug Name or NDC

    NDC 00517-4300-01 Paclitaxel 100 mg/20mL Details

    Paclitaxel 100 mg/20mL

    Paclitaxel is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Regent, Inc.. The primary component is PACLITAXEL.

    Product Information

    NDC 00517-4300
    Product ID 0517-4300_2af4cfae-b569-4445-86f4-b11aba1a4538
    Associated GPIs
    GCN Sequence Number 058624
    GCN Sequence Number Description paclitaxel protein-bound VIAL 100 MG INTRAVEN
    HIC3 V1F
    HIC3 Description ANTINEOPLASTICS,MISCELLANEOUS
    GCN 24094
    HICL Sequence Number 026856
    HICL Sequence Number Description PACLITAXEL PROTEIN-BOUND
    Brand/Generic Generic
    Proprietary Name Paclitaxel
    Proprietary Name Suffix n/a
    Non-Proprietary Name Paclitaxel
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
    Route INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/20mL
    Substance Name PACLITAXEL
    Labeler Name American Regent, Inc.
    Pharmaceutical Class Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211875
    Listing Certified Through 2024-12-31

    Package

    NDC 00517-4300-01 (00517430001)

    NDC Package Code 0517-4300-01
    Billing NDC 00517430001
    Package 1 VIAL in 1 CARTON (0517-4300-01) / 20 mL in 1 VIAL
    Marketing Start Date 2023-05-02
    NDC Exclude Flag N
    Pricing Information N/A